Market Currents
Acadia Pharmaceuticals (ACAD) reports Q4 results in line with EPS loss estimates but beats on...
-
Tuesday, March 6, 2012, 4:18 PM ETAcadia Pharmaceuticals (ACAD) reports Q4 results in line with EPS loss estimates but beats on revenue, largely due to the conclusion of its collaboration with Biovail in October 2010.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
